• FDA DYMISTA NDA 202236 approval records — 22 FDA documents, 848 pages
1 1

FDA 510(k) K031373, IXL DIABETES MANAGEMENT SYSTEM, by Insulet Corp.

FDA 510(k) K031373, IXL DIABETES MANAGEMENT SYSTEM, by Insulet Corp.

$89.00 USD
$89.00 USD
Sale Sold out
510(K) Number: K031373
Device Name: IXL DIABETES MANAGEMENT SYSTEM
Manufacturer: Insulet Corp.
Device Classification Name: pump, infusion, insulin
Regulation Number: 880.5725
Classification Product Code: LZG
Date Received: 04/30/2003
Decision Date: 12/19/2003
Regulation Medical Specialty: General Hospital
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome